Literature DB >> 8153670

Quality-of-life issues in patients with malignant gliomas.

R D Aiken1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8153670

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Impairment of medical decisional capacity in relation to Karnofsky Performance Status in adults with malignant brain tumor.

Authors:  Roy C Martin; Adam Gerstenecker; Louis B Nabors; Daniel C Marson; Kristen L Triebel
Journal:  Neurooncol Pract       Date:  2014-12-04

2.  Treatment of malignant gliomas in the elderly.

Authors:  J Y Pierga; K Hoang-Xuan; L Feuvret; J M Simon; P Cornu; F Baillet; J J Mazeron; J Y Delattre
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

Review 3.  Management of primary malignant brain tumours.

Authors:  I R Whittle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

Review 4.  Complications and expected outcome of glioma surgery.

Authors:  K P Vives; J M Piepmeier
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

5.  Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues.

Authors:  Guy Pelletier; Marja J Verhoef; Nasreen Khatri; Neil Hagen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

6.  Health-related quality of life of long-term high-grade glioma survivors.

Authors:  Ingeborg Bosma; Jaap C Reijneveld; Linda Douw; Maaike J Vos; Tjeerd J Postma; Neil K Aaronson; Martin Muller; W Peter Vandertop; Ben J Slotman; Martin J B Taphoorn; Jan J Heimans; Martin Klein
Journal:  Neuro Oncol       Date:  2008-07-10       Impact factor: 12.300

7.  Use of the "Exposome" in the Practice of Epidemiology: A Primer on -Omic Technologies.

Authors:  D Gayle DeBord; Tania Carreón; Thomas J Lentz; Paul J Middendorf; Mark D Hoover; Paul A Schulte
Journal:  Am J Epidemiol       Date:  2016-08-15       Impact factor: 4.897

8.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Authors:  G Minniti; V De Sanctis; R Muni; F Filippone; A Bozzao; M Valeriani; M F Osti; U De Paula; G Lanzetta; V Tombolini; R Maurizi Enrici
Journal:  J Neurooncol       Date:  2008-02-05       Impact factor: 4.130
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.